Arcutis Biotherapeutics Inc (ARQT) Insider Trading
- $26,579,888.32
- $24,425,732.15
- Nov. 15, 2024
- Todd Franklin Watanabe
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 3, 2020 | Director | 2,800 | $25.63 | Sell | $71,764.00 | |
| Feb. 4, 2020 | Major Shareholder | 500,000 | $24.10 | Buy | $12,050,000.00 | |
| Feb. 3, 2020 | Director | 558,888 | $25.64 | Buy | $14,329,888.32 |
Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.
The insider traders at Arcutis Biotherapeutics Inc are: Todd Franklin Watanabe, Howard G Welgus, Patrick Burnett, Masaru Matsuda, Bhaskar Chaudhuri, Scott L Burrows, John W. Smither, Patricia A Turney, Orbimed Advisors Llc, Life Sciences Viii L Frazier, Larry Todd Edwards, Howard G. Welgus, David W Osborne, Welgus Howard G., Terrie Curran, David Joseph Topper, Watanabe Todd Franklin, Jonathan Silverstein, David W. Osborne, and OSBORNE DAVID W
The most active insider trader at Arcutis Biotherapeutics Inc is Todd Franklin Watanabe with 28 trades.
Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.
Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.
The most recent insider trade for Arcutis Biotherapeutics Inc was on Nov. 15, 2024.
The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.
The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.